e-Therapeutics says company faces lack of interest as UK listing
(Alliance News) - e-Therapeutics PLC on Wednesday announced its intention to cancel its admission to AIM and instead explore the option of listing on the NASDAQ exchange. Read More
ETX.L (ETX) Latest Trades |
||||
Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
---|
ETX.L (ETX) Regulatory News |
||
Date | Source | Headline |
---|---|---|
9th May 2024 7:00 am | RNS | Cancellation - e-Therapeutics Plc |
8th May 2024 7:00 am | RNS | Last Day of Dealings on AIM |
3rd May 2024 6:00 pm | RNS | e-therapeutics |
29th Apr 2024 2:09 pm | RNS | Result of General Meeting |
10th Apr 2024 7:00 am | RNS | Proposed Fundraise of £28.9m and Cancellation |
31st Jan 2024 4:30 pm | RNS | Total Voting Rights |
24th Jan 2024 10:04 am | RNS | Exercise of Options and Issue of Equity |
16th Jan 2024 7:00 am | RNS | Business Update |
9th Jan 2024 4:04 pm | RNS | Director Dealing and Issue of Equity |
27th Dec 2023 7:00 am | RNS | Update on OTCQX Market Listing |